about
Cilostazol for intermittent claudicationPharmacological treatment for Buerger's diseasePropionyl-L-carnitine for intermittent claudicationGinkgo biloba for intermittent claudicationCilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial originSarpogrelate for peripheral arterial diseaseGinkgo biloba for intermittent claudicationPractice-based evidence: profiling the safety of cilostazol by text-mining of clinical notesPatterns of femoropopliteal recurrence after routine and selective stenting endoluminal therapy.A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication.Pharmacology in peripheral arterial disease: what the interventional radiologist needs to know.Systematic reviews and meta-analyses for more profitable strategies in peripheral artery diseasePeripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes.Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Optimal management of peripheral arterial disease for the non-specialistAge, male gender, and atrial fibrillation predict lower extremity amputation or revascularization in patients with peripheral artery diseases: a population-based investigation.Targeting phosphodiesterase 3B enhances cisplatin sensitivity in human cancer cells.RETRACTED: PURLs: ramipril for claudication?Role of colesevelam in managing heterozygous familial hypercholesterolemia in adolescents and children.The role of oral vitamin K antagonists in the outcome of infrainguinal bypass procedures.Comparative Effectiveness of Medical Therapy, Supervised Exercise, and Revascularization for Patients With Intermittent Claudication: A Network Meta-analysis.Pharmacological treatment of intermittent claudication does not have a significant effect on gait impairments during claudication pain.Determinants of lower extremity amputation or revascularization procedure in patients with peripheral artery diseases: a population-based investigation.
P2860
Q24193019-4B61E8D2-0F20-476D-9C1E-AEB36BBB861AQ24198267-5B5586AF-0270-4B99-9C91-4A8DDE20DB18Q24201080-51C50C16-3DC6-4A58-8D1D-3EDC809DFBB5Q24202149-6D600581-DCE3-4B94-8AA4-1094E2D34A7DQ24234846-884D7B8C-37B5-45D8-B11D-7B89605AD25EQ24240316-115C358A-BB34-48D0-AEDD-3526092608CCQ24241126-0AB3C139-1758-47B5-8551-5775FA17A843Q28533275-042E9162-D2E6-4F59-805E-F924977A41E6Q33635120-001B3016-884C-4D31-BB89-42C6F82F5454Q33903841-2106EAAB-8457-41C6-9A12-43FB75E77450Q34513880-108B1BD4-5E0B-43C0-AB7C-24C727E95147Q34576281-E0ABB058-686F-4A16-9057-C8540339E52CQ34625055-B89794FE-1260-4E0B-91F9-54CE27F2B352Q35752591-2033897A-A654-4B3C-9E13-2924EFCEAB94Q35761784-C2B59773-3C6D-4EA6-8A43-FFE00752B78BQ36238939-EBE7AB7D-6AE8-4D6C-96C3-7B10E2566B80Q37231987-D92955AC-75E4-40D5-8DCE-DC9645D21F35Q37479381-619FDBE8-B300-4D96-B686-D538AA36861AQ37561301-51805D11-E016-467A-AA3A-D80690D449C4Q38134336-FC5AB5A1-2CC8-49DA-BD2E-2950F3A85A31Q40951369-D7DEAB3C-66B9-4DB5-8FAA-8A45E8603B9CQ41904181-3E460283-8620-4F5D-A4F9-6CD11E97ED37Q51542719-A7BE1683-667D-4377-8A47-CD4EF4F04EFE
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Cilostazol for peripheral arterial disease
@ast
Cilostazol for peripheral arterial disease
@en
Cilostazol for peripheral arterial disease
@en-gb
Cilostazol for peripheral arterial disease
@nl
type
label
Cilostazol for peripheral arterial disease
@ast
Cilostazol for peripheral arterial disease
@en
Cilostazol for peripheral arterial disease
@en-gb
Cilostazol for peripheral arterial disease
@nl
prefLabel
Cilostazol for peripheral arterial disease
@ast
Cilostazol for peripheral arterial disease
@en
Cilostazol for peripheral arterial disease
@en-gb
Cilostazol for peripheral arterial disease
@nl
P2093
P2860
P1476
Cilostazol for peripheral arterial disease
@en
P2093
Dimitris P Mikhailidis
Gerard P Stansby
Peter Robless
P2860
P356
10.1002/14651858.CD003748.PUB3
P577
2008-01-23T00:00:00Z